NO137941C - Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin - Google Patents

Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin

Info

Publication number
NO137941C
NO137941C NO3084/73A NO308473A NO137941C NO 137941 C NO137941 C NO 137941C NO 3084/73 A NO3084/73 A NO 3084/73A NO 308473 A NO308473 A NO 308473A NO 137941 C NO137941 C NO 137941C
Authority
NO
Norway
Prior art keywords
toluenesulphonate
adenosyl
methionine
preparation
therapeutically active
Prior art date
Application number
NO3084/73A
Other languages
English (en)
Norwegian (no)
Other versions
NO137941B (no
Inventor
Alberto Fiecchi
Original Assignee
Bioresearch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bioresearch filed Critical Bioresearch
Publication of NO137941B publication Critical patent/NO137941B/no
Publication of NO137941C publication Critical patent/NO137941C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/26Preparation of nitrogen-containing carbohydrates
    • C12P19/28N-glycosides
    • C12P19/38Nucleosides
    • C12P19/40Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
NO3084/73A 1972-08-02 1973-08-01 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin NO137941C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2779372 1972-08-02

Publications (2)

Publication Number Publication Date
NO137941B NO137941B (no) 1978-02-13
NO137941C true NO137941C (no) 1978-05-31

Family

ID=11222342

Family Applications (1)

Application Number Title Priority Date Filing Date
NO3084/73A NO137941C (no) 1972-08-02 1973-08-01 Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin

Country Status (29)

Country Link
US (1) US3893999A (fr)
JP (1) JPS5235726B2 (fr)
AR (1) AR195350A1 (fr)
AT (1) AT341684B (fr)
AU (1) AU474015B2 (fr)
BE (1) BE802981A (fr)
CA (1) CA1006872A (fr)
CH (1) CH592112A5 (fr)
CS (1) CS195254B2 (fr)
DD (1) DD107461A5 (fr)
DE (1) DE2336401C3 (fr)
DK (1) DK131868C (fr)
ES (1) ES417377A1 (fr)
FI (1) FI52466C (fr)
FR (1) FR2194425B1 (fr)
GB (1) GB1425384A (fr)
HK (1) HK31580A (fr)
HU (1) HU167266B (fr)
IE (1) IE37913B1 (fr)
IL (1) IL42764A (fr)
MX (1) MX4544E (fr)
NL (1) NL152864B (fr)
NO (1) NO137941C (fr)
PL (1) PL87381B1 (fr)
RO (1) RO63451A (fr)
SE (1) SE400085B (fr)
SU (1) SU646915A3 (fr)
YU (1) YU36037B (fr)
ZA (1) ZA734876B (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE39517B1 (en) * 1973-06-27 1978-10-25 Bioresearch Sas Double salts of s-adenosyl-l-methhionine
AR221676A1 (es) * 1974-07-12 1981-03-13 Bioresearch Sas Procedimiento para la preparacion de sales estables sulfonicas y/o sulfuricas de la s-adenosil-l-metionina,particularmente utiles como donadores especificos de metilo para las reacciones bioquimicas de transferencia del grupo ch3;asi como tambien las reacciones fundamentales en el metabolismo lipilico,protilico y glucidico
DE2646269A1 (de) * 1975-10-16 1977-04-28 Yamasa Shoyu Kk Stabilisierte s-adenosyl-l-methionin- zubereitung und verfahren zur herstellung derselben
GB2064523B (en) * 1979-12-04 1983-06-29 Kanegafuchi Chemical Ind Stable composition of s-adenosyl-l-methionine
IT1137640B (it) 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1137892B (it) * 1981-08-24 1986-09-10 Bioresearch Srl Sali stabili della s-adenosilmetionina,processo per la loro preparazione e composizioni terapeutiche che li comprendono come principio attivo
IT1139974B (it) * 1981-09-11 1986-09-24 Bioresearch Srl Derivati della s-adenosilmetionina,processo per la preparazione e composizioni terapeutiche che li contengono come principio attivo
IT1169773B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Processo per la produzione di sali stabili della solfo-adenosil-l-metionina
IT1169774B (it) * 1983-08-24 1987-06-03 Bioresearch Spa Composizioni terapeutiche iniettabili contenenti sali stabili della s-adenosil-l-metionina
IT1173992B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente idonei per uso farmaceutico orale
IT1173990B (it) * 1984-05-16 1987-06-24 Bioresearch Spa Sali stabili della solfo-adenosil-l-metionina (same) particolarmente adatti per uso parenterale
IT1200589B (it) * 1985-02-14 1989-01-27 Gibipharma Spa Derivati naturali attivita farmagologica
ATE80165T1 (de) * 1987-10-09 1992-09-15 Vincenzo Zappia Lipophile salze von s-adenosyl-l-methionin (sam) mit acyltaurinderivaten.
DE19515275A1 (de) * 1995-04-26 1996-10-31 Knoll Ag Neue Verwendung von (S)-Adenosyl-L-methionin(SAMe)
US6759395B2 (en) 2000-12-18 2004-07-06 Orchid Chemicals & Pharmaceuticals, Ltd. Soft-gelatin capsule comprising S-adenosylmethionine and a method for producing the same
WO2006079212A1 (fr) * 2005-01-26 2006-08-03 Diamedica Inc. Utilisation du compose s-adenosylmethionine, de la vitamine e, et de la vitamine c pour traiter les lesions hepatiques et la resistance a l'insuline causees par le stress oxydatif
US20090012036A1 (en) * 2005-05-24 2009-01-08 Hebert Rolland F Stable S-adenosyl-L-methionine
ITMI20060629A1 (it) 2006-03-31 2007-10-01 Daniele Giovannone Composizioni solide orali a base di s-adenosilmetionina e processo per il loro ottenimento
US20090197824A1 (en) * 2008-01-31 2009-08-06 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
US20090088404A1 (en) * 2007-01-31 2009-04-02 Methylation Sciences International Srl Extended Release Pharmaceutical Formulations of S-Adenosylmethionine
JP2010518021A (ja) * 2007-01-31 2010-05-27 メチレーション・サイエンシーズ・インターナショナル・ソサイアティーズ・ウィズ・リストリクティッド・ライアビリティ S−アデノシルメチオニンの持続放出医薬製剤
ITMI20071374A1 (it) * 2007-07-10 2009-01-11 Gnosis Spa Sali stabili di s-adenosilmetionina e processo per il loro ottenimento.
US20100004191A1 (en) * 2008-07-01 2010-01-07 Rolland F Hebert Compositions of S-adenosyl-L-methionine.
US8329208B2 (en) 2009-07-28 2012-12-11 Methylation Sciences International Srl Pharmacokinetics of S-adenosylmethionine formulations
US20110027342A1 (en) * 2009-07-28 2011-02-03 Msi Methylation Sciences, Inc. S-adenosylmethionine formulations with enhanced bioavailability
AU2012243363A1 (en) * 2011-04-15 2013-11-28 Scimar Ltd. Use of E-adenosylmethionine, vitamin E, and vitamin C for the prevention and treatment of cardiovascular dysfunction
AU2013332209B2 (en) 2012-10-17 2016-02-04 Methylation Sciences International Srl Compositions comprising S-adenosylmethionine and a gallic acid ester
EP2945959B1 (fr) 2013-01-16 2020-05-13 Hebert Sam-E LLC S-adenosyl-l-methionine sous forme de sels d'indole-3-propionate stables

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2946781A (en) * 1957-02-06 1960-07-26 Merck & Co Inc Process for the preparation of adenosyl homocysteine
US3642772A (en) * 1968-09-04 1972-02-15 Boehringer Mannheim Gmbh Process for preparing s-adenosyl homocysteine

Also Published As

Publication number Publication date
DD107461A5 (fr) 1974-08-05
IL42764A0 (en) 1974-01-14
DK131868B (da) 1975-09-15
IL42764A (en) 1976-04-30
YU203073A (en) 1981-04-30
DE2336401A1 (de) 1974-02-14
FR2194425B1 (fr) 1976-04-09
RO63451A (fr) 1978-07-15
BE802981A (fr) 1973-11-16
ATA664173A (de) 1977-06-15
ZA734876B (en) 1974-06-26
IE37913B1 (en) 1977-11-09
DE2336401C3 (de) 1980-03-13
FI52466B (fr) 1977-05-31
FI52466C (fi) 1977-09-12
JPS5235726B2 (fr) 1977-09-10
YU36037B (en) 1981-11-13
JPS4992215A (fr) 1974-09-03
NL152864B (nl) 1977-04-15
NO137941B (no) 1978-02-13
PL87381B1 (fr) 1976-06-30
CH592112A5 (fr) 1977-10-14
MX4544E (es) 1982-06-08
CA1006872A (en) 1977-03-15
US3893999A (en) 1975-07-08
CS195254B2 (en) 1980-01-31
AT341684B (de) 1978-02-27
SE400085B (sv) 1978-03-13
SU646915A3 (ru) 1979-02-05
GB1425384A (en) 1976-02-18
DK131868C (da) 1976-03-08
DE2336401B2 (de) 1979-07-12
HU167266B (fr) 1975-09-27
AR195350A1 (es) 1973-09-28
HK31580A (en) 1980-06-20
AU474015B2 (en) 1976-07-08
FR2194425A1 (fr) 1974-03-01
ES417377A1 (es) 1976-02-16
NL7310706A (fr) 1974-02-05
AU5868073A (en) 1975-01-30
IE37913L (en) 1974-02-02

Similar Documents

Publication Publication Date Title
NO137941C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktivt tri-p-toluensulfonat av s-adenosyl-l-methionin
NO793013L (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive benzodiazepinderivater
NO139560C (no) Analogifremgangsmaate til fremstilling av terapeutisk virksomme nonapeptidamid-derivater
NO140059C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinderivater
NO140381C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arylpiperaziner
NO781312L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-merkaptotiadiazol- eller merkaptotetrazol-cefalosporiner
NO138565C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive piperazinyl-propyl-1,2,4-triazolinonderivater
NO140058C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive substituerte piperidinoalkanol-oxim-derivater
NO137694C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzomorfaner
NO138999C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive difenylyl-alkanoylaminopyridiner
NO140057C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive alfa-aryl-4-substituerte piperidinoalkanol-derivater
NO137824C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive fenylalkyltetrazoler
NO140670C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyrazolodiazepinderivater
NO137858C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive indanoner
NO137151C (no) Analogifremgangsm}te for fremstilling av terapeutisk aktive ortiotropin-peptider
NO138063C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive normorfinon-derivater
NO137728C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrasi-4-oksyd-derivater
NO140299C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive 4-aryl-5-aminoalkyl-4-oksazolin-2-oner
NO138026C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive n-benzhydryl-n`-p-hydroksybenzylpiperaziner
NO138251C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzylaminer
NO139050C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nororipavin- og tebainderivater
NO138285C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive lincomycinderivater
NO140007C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive indolcarboxylsyrer
NO137695C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-tienylmetyl-heterocykliske forbindelser
NO138908C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive imidazo- og pyrazolo-isokinolinderivater